Actively Recruiting
Wheelchair Seating Users With Neuromuscular Diseases: Elaboration of a Prognostic Score of Changes on the Seating System of the Wheelchair
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-03-19
368
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating a prognostic score to predict when wheelchair users with neuromuscular diseases may need changes to their seating system. This study focuses on adults who use wheelchairs daily due to conditions like Duchenne muscular dystrophy or infantile spinal muscular atrophy type II. The goal is to guide healthcare professionals in deciding when a patient requires a reassessment of their seated posture to prevent complications such as pain, stiffness, and spinal deformities. Participants are divided into two groups: a development cohort and a validation cohort across multiple centers. Each participant receives usual care, which includes at least two multidisciplinary consultations during annual visits. The study tracks changes in the wheelchair seating system over a 12-month period to evaluate the prognostic score. Throughout the study, participants will undergo assessments measuring seated postural control, pain levels, pressure ulcers, comfort, and postural stability at the beginning and end of the 12 months. Researchers will monitor adverse events during this time. The study aims to provide a reliable tool that healthcare providers can use to improve daily quality of life for wheelchair users by timely identifying the need for seating adjustments.
CONDITIONS
Brief Title
Elaboration of a Pronostic Score of Changes on Wheelchair's Seating System
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female over the age of 18
- Daily wheelchair user (more than 4 hours per day)
- Having a neuromuscular disease such as Duchenne Muscular Dystrophy or Infantile Spinal Muscular Atrophy type II
- Accompanied by an identified medical equipment provider, able to respond to the recommendations of the clinical team
- Patient informed and having signed consent.
You will not qualify if you...
- Person who already has a seat change or FR prescription at the time of inclusion
- Having undergone surgery less than 1 year ago or a fracture
- Pregnant or breastfeeding women
- Patient under guardianship or curatorship.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 12 months
Participants who undergo routine care are observed during annual visits with a multidisciplinary consultation to assess their wheelchair seating system and related health outcomes.
At least 2 annual visits (in-person)
Trial Site Locations
Total: 1 location
1
New technology Platform department, Raymond Poincaré Hospital, APHP
Garches, France, 92380
Actively Recruiting
Research Team
S
Samuel Pouplin, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here